Acute Otitis Media Management

Diagnosis and Initial Management

The American Academy of Pediatrics recommends that proper diagnosis of acute otitis media requires three essential elements: acute onset of symptoms, presence of middle ear effusion, and signs of middle ear inflammation, with a strength of evidence level I 1
The American Academy of Pediatrics suggests that isolated redness of the tympanic membrane with normal landmarks is not an indication for antibiotic therapy, with a strength of evidence level II 3

The American Academy of Pediatrics recommends addressing pain immediately during the first 24 hours using oral acetaminophen or ibuprofen, regardless of whether antibiotics are prescribed, with a strength of evidence level I 1

The American Academy of Pediatrics recommends high-dose amoxicillin at 80-90 mg/kg/day divided into two daily doses as the first-line choice for children, due to effectiveness against susceptible and intermediate-resistant Streptococcus pneumoniae, with a strength of evidence level I 1
The Infectious Diseases Society of America recommends amoxicillin-clavulanate (3 g/day amoxicillin component) as first-line therapy in adults because it provides coverage against beta-lactamase-producing organisms, with a strength of evidence level I 3, 2

The American Academy of Pediatrics suggests considering observation without immediate antibiotics for otherwise healthy children aged 6 months to 2 years with non-severe illness and uncertain diagnosis, with a strength of evidence level II 1

The American Academy of Pediatrics recommends 10 days of treatment for children <2 years and those with severe symptoms, with a strength of evidence level I 1
The American Academy of Pediatrics recommends 7 days of treatment for children 2-5 years with mild-to-moderate disease, with a strength of evidence level I 1
The American Academy of Pediatrics recommends 5-7 days of treatment for children ≥6 years and adults with mild-to-moderate disease, with a strength of evidence level I 1, 2

The American Academy of Pediatrics defines treatment failure as worsening condition, persistence of symptoms beyond 48-72 hours after antibiotic initiation, or recurrence of symptoms within 4 days of treatment discontinuation, with a strength of evidence level II 2
The American Academy of Pediatrics recommends reassessing patients at 48-72 hours to confirm AOM diagnosis and exclude other causes of illness, with a strength of evidence level II 1, 2

The Centers for Disease Control and Prevention identifies Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis as the three most common bacterial pathogens, with a strength of evidence level I 3, 1

The Centers for Disease Control and Prevention recommends ensuring pneumococcal conjugate vaccine (PCV) is up-to-date, with a strength of evidence level I 1
The American Academy of Pediatrics suggests considering annual influenza vaccination, with a strength of evidence level II 1